Try our Advanced Search for more refined results

IN RE: TYLENOL (ACETAMINOPHEN) MARKETING, SALES PRACTICES AND PRODUCTS LIABILITY LITIGATION

Track this case

Case overview

Case Number:

2:13-md-02436

Court:

Pennsylvania Eastern

Nature of Suit:

P.I.: Personal Inj. Prod. Liability

Multi Party Litigation:

Multi-district Litigation

Judge:

BERLE M. SCHILLER

  1. July 28, 2016

    More Expert Testimony Allowed In 1st Tylenol Bellwether

    A Pennsylvania federal judge on Thursday allowed several expert witnesses to testify in the upcoming first bellwether trial in multidistrict litigation over the alleged liver damage risks of Johnson & Johnson Tylenol products on causation and regulatory issues, placing some caveats on what opinions they can offer.

  2. July 26, 2016

    J&J Can't Nix Causation Experts In 1st Tylenol Bellwether

    A Pennsylvania federal judge on Tuesday denied Johnson & Johnson's bids to prevent two causation experts from testifying during the first bellwether trial in multidistrict litigation over the alleged liver damage risks of various Tylenol products, rejecting the company's arguments that their opinions weren't reliable.

  3. June 06, 2016

    J&J Won't Have To Avoid New Ads Before Liver Damage Trial

    A Pennsylvania federal judge on Friday nixed a bid by a woman, who is suing Johnson & Johnson over her sister's death in multidistrict litigation over the alleged liver damage risks of various Tylenol products, to stop the company from running any new publicity campaigns before the first bellwether trial.

  4. April 20, 2016

    Drug Labels Must Reflect Risk Sooner, Tylenol Court Told

    A woman suing Johnson & Johnson over her sister's death in the first bellwether trial in multidistrict litigation over the alleged liver damage risks of various Tylenol products on Wednesday told a Pennsylvania federal court that drugmakers must enhance label warnings as soon as there's reasonable evidence that the drug is associated with a risk.

  5. April 19, 2016

    J&J Loses Bids To Limit Testimony In Tylenol Bellwether

    A Pennsylvania federal judge on Tuesday for the most part shot down bids from Johnson & Johnson to keep evidence, such as promotional marketing or media reports, from the first bellwether trial in multidistrict litigation over the alleged liver damage risks of various Tylenol products.

  6. November 13, 2015

    J&J Can't Pare Tylenol Liver Damage Bellwether: Pa. Judge

    A Pennsylvania federal judge on Friday rejected bids by Johnson & Johnson and a subsidiary to toss a slew of allegations from the first bellwether trial in multidistrict litigation over the alleged liver damage risks of various Tylenol products.

  7. June 15, 2015

    J&J Attys, Witnesses Can't Reveal Own Tylenol Use: Plaintiffs

    Plaintiffs targeting Johnson & Johnson and its subsidiary McNeil-PPC Inc. in multidistrict litigation over the alleged liver damage risks of various Tylenol products argued Friday that the defendants should not be allowed to testify that their counsel or witnesses have themselves taken the drugs or suffered tragedies.

  8. May 21, 2015

    Judge OKs Unlimited Damages For Tylenol Liver Bellwether

    A Pennsylvania federal judge on Wednesday ruled that plaintiffs can seek unlimited punitive damages under Alabama law in the first bellwether trial later this year in multidistrict litigation alleging the acetaminophen in various Tylenol products from a Johnson & Johnson Inc. unit was responsible for users' severe liver damage.

  9. January 29, 2015

    Tylenol Liver-Damage MDL Bellwether Gets June Trial Date

    A Pennsylvania federal judge on Thursday set a late June trial date for the first bellwether case in multidistrict litigation alleging the acetaminophen in various Tylenol products from a Johnson & Johnson Inc. unit was responsible for users' severe liver damage.

  10. April 01, 2013

    J&J Must Face Tylenol Liver Damage MDL In Pa.

    The U.S. Judicial Panel on Multidistrict Litigation on Monday centralized in Pennsylvania's Eastern District 27 lawsuits alleging that acetaminophen in various Tylenol products was responsible for users' severe liver damage.